InVivo Therapeutics to Present at Neuroscience 2016

CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) will present data from its ongoing nonclinical study of Neuro-Spinal Scaffold™ implantation at Neuroscience 2016, the Society for Neuroscience 46th annual conference November 12-16 in San Diego. The company’s oral presentation entitled “The Neuro-Spinal Scaffold promotes tissue remodeling, axonal sprouting, and Schwann cell myelination following acute spinal cord contusion injury in rats” will be presented by Simon Moore, Ph.D., Director of Research, on Monday, November 14 at 2:15 PM (PST) during the Brain and Spinal Cord Injury nanosymposium. “I look forward to sharing these latest Neuro-Spinal Scaffold nonclinical findings with the neuroscience community,” Dr. Moore said. “In the data to be presented at Neuroscience 2016, we examine findings regarding spinal cord preservation, neural regeneration and remyelination in animal models of spinal cord injury, contributing…

Link to Full Article: InVivo Therapeutics to Present at Neuroscience 2016

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!